Gujarat Alkalies and Chemicals Limited

NSE:GUJALKALI.NS

816.95 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 38,066.345,16536,937.97123,521.13127,089.81931,460.90924,390.49920,520.87619,585.52619,374.81518,874.37417,994.99317,109.68114,231.73312,780.79313,868.21111,336.30410,448.351
Cost of Revenue 35,123.515,09514,101.63810,466.15710,417.8419,521.0697,409.2337,412.97913,117.3213,652.54512,325.84410,843.69310,702.9926,271.6915,841.095,040.053,581.8523,241.882
Gross Profit 2,942.830,07022,836.33313,054.97416,671.97821,939.8416,981.26613,107.8976,468.2065,722.276,548.537,151.36,406.6897,960.0426,939.7038,828.1617,754.4527,206.469
Gross Profit Ratio 0.0770.6660.6180.5550.6150.6970.6960.6390.330.2950.3470.3970.3740.5590.5430.6370.6840.69
Reseach & Development Expenses 43.25898.67912.63112.5412.32910.2237.58211.23711.19313.8029.9948.5514.92800000
General & Administrative Expenses 0422.267331.882301.392254.671165.206192.417314.262184.797168.039183.254196.948959.816547.898523.401713.721447.58406.652
Selling & Marketing Expenses 0457.468868.253637.257200.358171.08192.945250.674217.025244.121239.686215.684271.28400000
SG&A 5,356.6879.7351,200.135938.649455.029336.286385.362564.936401.822412.16422.94412.6321,231.1547.898523.401713.721447.58406.652
Other Expenses 180.6421.56.31610.1419.8694.5073.1951.9490.8850.5540.7380.7-46.6116,178.5525,348.2455,669.1815,005.4934,090.212
Operating Expenses 5,356.621,68514,881.88111,225.39212,423.44512,129.16610,374.5899,579.1064,185.6543,963.6334,320.0753,776.0663,835.3036,726.455,871.6466,382.9025,453.0734,496.864
Operating Income -2,413.88,731.737,896.7441,841.2844,225.0559,791.1476,606.6773,528.7912,282.5521,758.6372,228.4553,375.2342,571.3861,233.5921,068.0572,445.2592,301.3792,709.605
Operating Income Ratio -0.0630.1930.2140.0780.1560.3110.2710.1720.1170.0910.1180.1880.150.0870.0840.1760.2030.259
Total Other Income Expenses Net 455-1,780.687367.377505.623683.694371.357887.502276.936368.349396.131237.087-6.936-337.13237.573394.733167.781453.73525.335
Income Before Tax -1,958.86,951.18,264.1212,346.9074,908.74910,162.5047,494.1793,805.7272,650.9012,154.7682,465.5423,368.2982,234.2541,271.1651,462.792,613.042,755.1142,734.94
Income Before Tax Ratio -0.0510.1540.2240.10.1810.3230.3070.1850.1350.1110.1310.1870.1310.0890.1140.1880.2430.262
Income Tax Expense -636.42,854.92,666.488689.5341,587.8033,260.6542,149.215732.746434.235-123.803615.2821,014.755698.117128.137-255.648690.313514.257869.384
Net Income -2,368.44,096.25,597.6331,657.3733,320.9466,901.855,344.9643,072.9812,216.6662,278.5711,850.262,353.5431,536.1371,143.0281,718.4381,922.7272,240.8571,865.556
Net Income Ratio -0.0620.0910.1520.070.1230.2190.2190.150.1130.1180.0980.1310.090.080.1340.1390.1980.179
EPS -32.2555.7876.2222.5745.2293.9872.7841.8529.931.0325.232.0520.9215.5623.426.1830.5125.4
EPS Diluted -32.2555.7876.2222.5745.2293.9872.7841.8529.931.0325.232.0520.9215.5623.426.1830.5125.4
EBITDA 1,360.39,906.610,248.0424,191.856,674.84511,778.7228,422.7465,126.0043,804.833,131.7064,030.7645,068.0164,026.422,563.5042,285.9273,539.9533,292.7593,583.251
EBITDA Ratio 0.0360.2190.2770.1780.2460.3740.3450.250.1940.1620.2140.2820.2350.180.1790.2550.290.343